Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Peter Valent1, Cem Akin2, Patrizia Bonadonna3
1Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.
A new diagnostic algorithm helps identify mast cell activation (MCA) and mast cell activation syndrome (MCAS), distinguishing it from other conditions. This approach aims to prevent misdiagnoses and unnecessary referrals for patients with suspected MCAS.
Area of Science:
- Immunology
- Allergy and Clinical Immunology
- Internal Medicine
Background:
- Mast cell activation (MCA) is common, with mild symptoms often manageable by medication.
- Severe cases may suggest mast cell activation syndrome (MCAS), but overt MCAS is rare.
- Many patients suspected of MCAS have other conditions or milder MCA without meeting MCAS criteria.
Purpose of the Study:
- To propose a diagnostic algorithm for clinically relevant systemic MCA.
- To aid in documenting or excluding mast cell activation syndrome (MCAS).
- To guide clinicians in considering severe allergy and systemic mastocytosis as underlying causes of MCAS.
Main Methods:
- Development of a diagnostic algorithm for suspected mast cell activation syndrome (MCAS).
- The algorithm aims to differentiate MCAS from other conditions and identify underlying causes.
- Focus on guiding clinicians through the diagnostic process for patients with suspected MCA/MCAS.
Main Results:
- The proposed algorithm facilitates the suspicion of clinically relevant systemic MCA.
- It assists in the documentation or exclusion of mast cell activation syndrome (MCAS).
- The algorithm helps identify severe allergy and systemic mastocytosis as potential underlying diagnoses.
Conclusions:
- The diagnostic algorithm provides a structured approach to evaluating patients with suspected mast cell activation syndrome (MCAS).
- It aims to reduce misdiagnoses and unnecessary referrals by clarifying MCA and MCAS criteria.
- Further validation is needed, but the algorithm is anticipated to improve MCAS patient management.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Trial and Error and Algorithm
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Nephrotic Syndrome I : Introduction
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...


